KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Total Current Liabilities (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Total Current Liabilities for 17 consecutive years, with $16.5 billion as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 16.52% to $16.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.5 billion through Dec 2025, up 16.52% year-over-year, with the annual reading at $16.5 billion for FY2025, 16.52% up from the prior year.
  • Total Current Liabilities hit $16.5 billion in Q4 2025 for Abbott Laboratories, up from $14.6 billion in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $16.5 billion in Q4 2025 to a low of $12.4 billion in Q2 2022.
  • Historically, Total Current Liabilities has averaged $13.8 billion across 5 years, with a median of $13.6 billion in 2024.
  • Biggest five-year swings in Total Current Liabilities: rose 25.45% in 2021 and later decreased 10.64% in 2023.
  • Year by year, Total Current Liabilities stood at $13.1 billion in 2021, then grew by 18.19% to $15.5 billion in 2022, then fell by 10.64% to $13.8 billion in 2023, then grew by 2.28% to $14.2 billion in 2024, then increased by 16.52% to $16.5 billion in 2025.
  • Business Quant data shows Total Current Liabilities for ABT at $16.5 billion in Q4 2025, $14.6 billion in Q3 2025, and $13.4 billion in Q2 2025.